TP A3: Differential roles and cell type specific effects of IL-17A and IL-17F in epidermolysis bullosa acquisita

The project TP A3a continues TP 4 and A3 “The contribution of IL-17A and IL-17F in experimental epidermolysis bullosa acquisita” which have attributed an important role of the cytokine interleukin (IL)-17A in the effector phase of epidermolysis bullosa acquisita (EBA).

In the current study the cell-type specific effects mediated by the IL-17 receptor A on the pathogenesis of EBA is being elucidated.